GGrantIndex
← Leaderboards

Helmy M Siragy

University Of Virginia Charlottesville

$13,726,344
Attributed
$13,726,344
Total exposure
9
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $769.8K · FY200520
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20

Funding mix

By agency

NIH$13,726,344 · 9

By mechanism

R01$12,772,598 · 5
M01$953,746 · 4

Top collaborators

No co-investigators on record.

Most similar at University Of Virginia Charlottesville

Same institution · by research overlap

Others in their field

Top investigators on “Receptor Expression

Research focus

Receptor ExpressionKidneyMediatingLeadReceptorHypertensionInflammationMicrodialysisProgramsRattusRenin-Angiotensin SystemIn VitroReninIn VivoAngiotensinsMolecularFibrosisAngiotensin IiPathologicDiabetes MellitusCyclic GmpRegulationKidney DiseasesNovel Therapeutics

Grant awards (48)

(Pro)renin receptor regulates autophagy in diabetic kidney disease$405,000
R01 · FY2020 · HL · contact PI
(Pro)renin receptor mediates obesity induced hypertension$363,375
R01 · FY2020 · DK · contact PI
(Pro)renin receptor regulates autophagy in diabetic kidney disease$402,500
R01 · FY2019 · HL · contact PI
(Pro)renin receptor mediates obesity induced hypertension$363,375
R01 · FY2019 · DK · contact PI
(Pro)renin receptor regulates autophagy in diabetic kidney disease$403,750
R01 · FY2018 · HL · contact PI
(Pro)renin receptor mediates obesity induced hypertension$363,375
R01 · FY2018 · DK · contact PI
(Pro)renin receptor regulates autophagy in diabetic kidney disease$402,500
R01 · FY2017 · HL · contact PI
(Pro)renin receptor mediates obesity induced hypertension$362,344
R01 · FY2017 · DK · contact PI
Prorenin Receptor Mediates Early Changes in Diabetic Kidney$395,000
R01 · FY2016 · HL · contact PI
(Pro)renin receptor and renovascular hypertension$334,950
R01 · FY2016 · DK · contact PI
Prorenin Receptor Mediates Early Changes in Diabetic Kidney$389,075
R01 · FY2015 · HL · contact PI
(Pro)renin receptor and renovascular hypertension$334,950
R01 · FY2015 · DK · contact PI
Prorenin Receptor Mediates Early Changes in Diabetic Kidney$387,100
R01 · FY2014 · HL · contact PI
(Pro)renin receptor and renovascular hypertension$334,950
R01 · FY2014 · DK · contact PI
Prorenin Receptor Mediates Early Changes in Diabetic Kidney$376,040
R01 · FY2013 · HL · contact PI
(Pro)renin receptor and renovascular hypertension$323,226
R01 · FY2013 · DK · contact PI
Prorenin Receptors Mediate Hypertension and Kidney Disease in Diabetes$374,963
R01 · FY2012 · HL · contact PI
(Pro)renin receptor and renovascular hypertension$334,950
R01 · FY2012 · DK · contact PI
Prorenin Receptors Mediate Hypertension and Kidney Disease in Diabetes$378,750
R01 · FY2011 · HL · contact PI
Renin receptor provoked renal inflammation$298,307
R01 · FY2011 · DK · contact PI
Prorenin Receptors Mediate Hypertension and Kidney Disease in Diabetes$378,750
R01 · FY2010 · HL · contact PI
Renin receptor provoked renal inflammation$301,320
R01 · FY2010 · DK · contact PI
Prorenin Receptors Mediate Hypertension and Kidney Disease in Diabetes$378,750
R01 · FY2009 · HL · contact PI
Renin receptor provoked renal inflammation$304,364
R01 · FY2009 · DK · contact PI
Renin receptor provoked renal inflammation$86,733
R01 · FY2009 · DK · contact PI
Prorenin Receptors Mediate Hypertension and Kidney Disease in Diabetes$378,750
R01 · FY2008 · HL · contact PI
Renin receptor provoked renal inflammation$304,364
R01 · FY2008 · DK · contact PI
Renin receptor provoked renal inflammation$310,575
R01 · FY2007 · DK · contact PI
Angiotensin II Mediates Early Changes in Diabetic Kidney$277,855
R01 · FY2007 · DK · contact PI
Angiotensin II Mediates Early Changes in Diabetic Kidney$286,154
R01 · FY2006 · DK · contact PI
AT2 Receptor Modulates Renal Angiotensin II Levels$333,000
R01 · FY2005 · HL
Angiotensin II Mediates Early Changes in Diabetic Kidney$293,040
R01 · FY2005 · DK
AT2 Receptor Modulates Renal Angiotensin II Levels$333,000
R01 · FY2004 · HL
Angiotensin II Mediates Early Changes in Diabetic Kidney$293,040
R01 · FY2004 · DK
AT2 Receptor Modulates Renal Angiotensin II Levels$333,000
R01 · FY2003 · HL
Angiotensin II Mediates Early Changes in Diabetic Kidney$293,040
R01 · FY2003 · DK
AT2 Receptor Modulates Renal Angiotensin II Levels$331,080
R01 · FY2002 · HL
INHIBITION OF CYTOCHROME P450 ON THERAPY EFFECTS OF ANGIOTENSIN RECEPT BLOCKER$48,533
M01 · FY2002 · RR
INHIBITION OF CYTOCHROME P450 ON THERAPY EFFECTS OF ANGIOTENSIN RECEPT BLOCKER$48,533
M01 · FY2001 · RR
RHYTHMIC AND PULSATILE RELEASE OF ALDOSTERONE$248,088
M01 · FY2000 · RR
STUDY OF VALSARTAN IN PATIENTS W/ HYPERTENSION$248,088
M01 · FY2000 · RR
OPC 41061 IN PATIENTS W/ HYPONATREMIA$248,088
M01 · FY2000 · RR
NO AND EICOSANOID MEDIATE RENAL EFFECTS OF AT2 RECEPTORS$227,303
R01 · FY2000 · HL
OPC 41061 IN PATIENTS W/ HYPONATREMIA$28,104
M01 · FY2000 · RR
INHIBITION OF CYTOCHROME P450 ON THERAPY EFFECTS OF ANGIOTENSIN RECEPT BLOCKER$28,104
M01 · FY2000 · RR
RHYTHMIC AND PULSATILE RELEASE OF ALDOSTERONE$28,104
M01 · FY2000 · RR
STUDY OF VALSARTAN IN PATIENTS W/ HYPERTENSION$28,104
M01 · FY2000 · RR
INHIBITION OF CYTOCHROME P450 ON THERAPY EFFECTS OF ANGIOTENSIN RECEPT BLOCKER$0
M01 · FY2000 · RR